Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Buy
31,675
+24,128
+320% +$2.82M 1.05% 31
2026
Q1
$2.35M Sell
7,547
-23,141
-75% -$2.67M 0.67% 46
2025
Q4
$3.23M Buy
30,688
+406
+1% +$38.1K 0.95% 31
2025
Q3
$2.54M Buy
30,282
+1,810
+6% +$149K 0.77% 38
2025
Q2
$2.25M Buy
28,472
+2,109
+8% +$168K 0.74% 39
2025
Q1
$2.37M Buy
26,363
+225
+0.9% +$21K 0.78% 38
2024
Q4
$2.6M Buy
26,138
+271
+1% +$27.9K 0.87% 32
2024
Q3
$2.94M Sell
25,867
-399
-2% -$47.4K 0.96% 30
2024
Q2
$3.25M Sell
26,266
-257
-1% -$33.1K 1.14% 29
2024
Q1
$3.5M Sell
26,523
-112
-0.4% -$13.8K 1.26% 29
2023
Q4
$2.9M Sell
26,635
-504
-2% -$52.3K 1.17% 28
2023
Q3
$2.79M Sell
27,139
-166
-0.6% -$17.9K 1.21% 30
2023
Q2
$3.15M Sell
27,305
-397
-1% -$45.1K 1.33% 28
2023
Q1
$2.95M Buy
27,702
+43
+0.2% +$4.64K 1.26% 28
2022
Q4
$3.07M Sell
27,659
-5,641
-17% -$577K 1.35% 28
2022
Q3
$2.87M Buy
33,300
+1,905
+6% +$170K 1.41% 25
2022
Q2
$2.86M Buy
31,395
+647
+2% +$57.4K 1.34% 25
2022
Q1
$2.52M Buy
30,748
+4,721
+18% +$372K 1.07% 29
2021
Q4
$2M Sell
26,027
-3,649
-12% -$291K 0.89% 35
2021
Q3
$2.23M Buy
29,676
+575
+2% +$43.7K 1.07% 30
2021
Q2
$2.26M Buy
29,101
+4,601
+19% +$342K 1.07% 30
2021
Q1
$1.8M Buy
24,500
+4,179
+21% +$308K 0.93% 31
2020
Q4
$1.59M Sell
20,321
-3,277
-14% -$251K 0.89% 37
2020
Q3
$1.87M Sell
23,598
-3,887
-14% -$304K 1.21% 25
2020
Q2
$2.03M Sell
27,485
-1,860
-6% -$140K 1.32% 26
2020
Q1
$2.15M Buy
+29,345
New +$2.31M 1.55% 23

Other funds holding MRK

Stolper & Co's MRK Position: Q2 2026 in Review

Stolper & Co increased its Merck (MRK) stake by 320% in Q2 2026, buying an estimated $2.82M and bringing the position to 31,675 shares worth $4.07M. The position accounts for 1.05% of the portfolio, ranked #31.

Stolper & Co first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 822 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Stolper & Co held 31,675 shares of Merck worth $4.07M as of Q2 2026.
  • Stolper & Co bought 24,128 Merck shares in Q2 2026, an estimated $2.82M.
  • Merck made up 1.05% of Stolper & Co's portfolio in Q2 2026, its #31 holding.
  • Stolper & Co first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 822 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Stolper & Co's 13F filing for Q2 2026, filed 14 Jul 2026.